AR222013A1 - Procedimiento para la preparacion de derivados de i-(n-piperidino)-6,7-dimetoxi-ftalazina - Google Patents
Procedimiento para la preparacion de derivados de i-(n-piperidino)-6,7-dimetoxi-ftalazinaInfo
- Publication number
- AR222013A1 AR222013A1 AR272434A AR27243478A AR222013A1 AR 222013 A1 AR222013 A1 AR 222013A1 AR 272434 A AR272434 A AR 272434A AR 27243478 A AR27243478 A AR 27243478A AR 222013 A1 AR222013 A1 AR 222013A1
- Authority
- AR
- Argentina
- Prior art keywords
- ftalazina
- dimetoxi
- piperidine
- derivatives
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2358277 | 1977-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR222013A1 true AR222013A1 (es) | 1981-04-15 |
Family
ID=10198020
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR272434A AR222013A1 (es) | 1977-06-03 | 1978-06-02 | Procedimiento para la preparacion de derivados de i-(n-piperidino)-6,7-dimetoxi-ftalazina |
AR279935A AR223999A1 (es) | 1977-06-03 | 1980-02-12 | Un procedimiento para preparar derivados de i-(piperidino)-6,7-dimetoxiftalizina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR279935A AR223999A1 (es) | 1977-06-03 | 1980-02-12 | Un procedimiento para preparar derivados de i-(piperidino)-6,7-dimetoxiftalizina |
Country Status (29)
Country | Link |
---|---|
US (1) | US4289772A (es) |
JP (1) | JPS5416488A (es) |
AR (2) | AR222013A1 (es) |
AT (2) | AT362792B (es) |
AU (1) | AU505373B1 (es) |
BE (1) | BE867727A (es) |
CA (1) | CA1111850A (es) |
DD (1) | DD137355A5 (es) |
DE (1) | DE2824064A1 (es) |
DK (1) | DK248078A (es) |
EG (1) | EG13527A (es) |
ES (4) | ES470470A1 (es) |
FI (1) | FI781753A (es) |
FR (1) | FR2392986A1 (es) |
GB (1) | GB2000136B (es) |
GR (1) | GR74402B (es) |
HU (1) | HU179745B (es) |
IL (1) | IL54842A (es) |
IN (3) | IN148482B (es) |
IT (1) | IT1094944B (es) |
LU (1) | LU79761A1 (es) |
NL (1) | NL7806016A (es) |
NO (1) | NO781935L (es) |
NZ (1) | NZ187453A (es) |
PL (3) | PL113208B1 (es) |
PT (1) | PT68126A (es) |
SE (1) | SE7806519L (es) |
SU (2) | SU856383A3 (es) |
ZA (1) | ZA783183B (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4370328A (en) * | 1977-11-03 | 1983-01-25 | Pfizer Inc. | Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines |
IL59619A0 (en) * | 1979-03-28 | 1980-06-30 | Pfizer | Phthalazine derivatives,their preparation and pharmaceutical compositions containing them |
CA1173037A (en) * | 1980-03-01 | 1984-08-21 | John L. Archibald | Piperidino ureas as antidepressants |
GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
US4882354A (en) * | 1987-12-16 | 1989-11-21 | Norwich Eaton Pharmaceuticals, Inc. | N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents |
JP3169188B2 (ja) * | 1991-01-31 | 2001-05-21 | 杏林製薬株式会社 | カルバミン酸誘導体及びその製造方法 |
US5300515A (en) * | 1991-01-31 | 1994-04-05 | Kyorin Pharmaceutical Co., Ltd. | Carbamic acid derivatives and method for preparing the same |
EP0621267A1 (en) * | 1993-04-07 | 1994-10-26 | Shell Internationale Researchmaatschappij B.V. | Spiropiperidine derivatives and their use as fungicides |
AU5772196A (en) * | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
KR100485249B1 (ko) * | 1996-08-20 | 2005-09-09 | 에자이 가부시키가이샤 | 축합피리다진계화합물의발기기능부전증치료제 |
US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
BR0313534A (pt) * | 2002-08-16 | 2005-07-12 | Janssen Pharmaceutica Nv | Antagonistas de integrinade ácido carboxìlico de piperidinoìla |
US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
TW200630337A (en) | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
EP1981868A2 (en) * | 2006-01-27 | 2008-10-22 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US8247442B2 (en) | 2006-03-29 | 2012-08-21 | Purdue Pharma L.P. | Benzenesulfonamide compounds and their use |
WO2007118853A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
WO2007118854A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and the use thereof |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
EP1903037A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors |
EP1900731A1 (de) * | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US8399486B2 (en) | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
MX2010001080A (es) | 2007-08-07 | 2010-03-01 | Hoffmann La Roche | Pirrolidin-aril-eteres como antagonistas de receptor de nk3. |
ES2369955T3 (es) | 2007-08-22 | 2011-12-09 | F. Hoffmann-La Roche Ag | Pirrolidina-aril-éteres como antagonistas de receptores de nk3. |
MX2010002585A (es) * | 2007-09-14 | 2010-03-26 | Hoffmann La Roche | Derivados de piperidina como antagonistas del receptor nk3. |
WO2009040659A2 (en) | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
AR077014A1 (es) | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
CN113087654B (zh) * | 2021-04-15 | 2022-12-23 | 苏州昊帆生物股份有限公司 | 哌啶-4-丁胺的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1094044A (en) * | 1965-07-12 | 1967-12-06 | Vantorex Ltd | Phthalazine derivatives |
GB1199768A (en) | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
GB1293565A (en) | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
GB1460389A (en) | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
-
1978
- 1978-05-15 IN IN364/DEL/78A patent/IN148482B/en unknown
- 1978-06-01 PT PT68126A patent/PT68126A/pt unknown
- 1978-06-01 DE DE19782824064 patent/DE2824064A1/de not_active Ceased
- 1978-06-01 FI FI781753A patent/FI781753A/fi not_active Application Discontinuation
- 1978-06-01 JP JP6627978A patent/JPS5416488A/ja active Granted
- 1978-06-01 GR GR56414A patent/GR74402B/el unknown
- 1978-06-01 GB GB7826202A patent/GB2000136B/en not_active Expired
- 1978-06-01 IL IL54842A patent/IL54842A/xx unknown
- 1978-06-01 BE BE188257A patent/BE867727A/xx unknown
- 1978-06-01 IT IT24106/78A patent/IT1094944B/it active
- 1978-06-01 NZ NZ187453A patent/NZ187453A/xx unknown
- 1978-06-02 FR FR7816545A patent/FR2392986A1/fr active Granted
- 1978-06-02 ZA ZA00783183A patent/ZA783183B/xx unknown
- 1978-06-02 ES ES470470A patent/ES470470A1/es not_active Expired
- 1978-06-02 DK DK248078A patent/DK248078A/da not_active Application Discontinuation
- 1978-06-02 NO NO781935A patent/NO781935L/no unknown
- 1978-06-02 NL NL7806016A patent/NL7806016A/xx not_active Application Discontinuation
- 1978-06-02 DD DD78205751A patent/DD137355A5/xx unknown
- 1978-06-02 AR AR272434A patent/AR222013A1/es active
- 1978-06-02 PL PL1978207337A patent/PL113208B1/pl unknown
- 1978-06-02 PL PL1978217896A patent/PL116420B1/pl unknown
- 1978-06-02 PL PL1978217897A patent/PL116437B1/pl unknown
- 1978-06-02 SE SE7806519A patent/SE7806519L/xx unknown
- 1978-06-02 HU HU78PI629A patent/HU179745B/hu unknown
- 1978-06-02 SU SU782624349A patent/SU856383A3/ru active
- 1978-06-02 CA CA304,700A patent/CA1111850A/en not_active Expired
- 1978-06-02 LU LU79761A patent/LU79761A1/fr unknown
- 1978-06-02 AT AT0400878A patent/AT362792B/de not_active IP Right Cessation
- 1978-06-02 AU AU36839/78A patent/AU505373B1/en not_active Expired
- 1978-06-03 EG EG354/78A patent/EG13527A/xx active
-
1979
- 1979-03-01 ES ES478201A patent/ES478201A1/es not_active Expired
- 1979-03-01 ES ES478199A patent/ES478199A1/es not_active Expired
- 1979-03-01 ES ES478200A patent/ES478200A1/es not_active Expired
- 1979-06-18 SU SU792777649A patent/SU862826A3/ru active
- 1979-12-13 US US06/103,342 patent/US4289772A/en not_active Expired - Lifetime
-
1980
- 1980-02-12 AR AR279935A patent/AR223999A1/es active
- 1980-05-20 IN IN368/DEL/80A patent/IN149550B/en unknown
- 1980-06-10 AT AT0305080A patent/AT363096B/de not_active IP Right Cessation
-
1981
- 1981-01-13 IN IN19/DEL/81A patent/IN149973B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR222013A1 (es) | Procedimiento para la preparacion de derivados de i-(n-piperidino)-6,7-dimetoxi-ftalazina | |
MX5950E (es) | Procedimiento para la preparacion de derivados de la pirrolidin-2-ona | |
MX5527E (es) | Procedimiento para la preparacion de derivados de carboestirilo | |
AR219560A1 (es) | Procedimiento para la preparacion de derivados de 5,5-dimetil-hidantoina | |
MX4988E (es) | Procedimiento para la preparacion de derivados pirrolidinicos | |
AR221851A1 (es) | Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina | |
AR222666A1 (es) | Procedimiento para preparar derivados de 5-tetrazolil dibenzo-(b,f)tiepinas | |
AR226694A1 (es) | Procedimiento para obtener nuevos derivados de antraciclina | |
AR225666A1 (es) | Procedimiento para la produccion de derivados para la produccion de derivados de 1-alquil-1-alquenil,alcoxi o alquil-3-5-alquil,fenil o halo-3-isoxazolilourea | |
MX5479E (es) | Procedimiento para la preparacion de derivados de 1-oxadetiacefalosporinas | |
MX5256E (es) | Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina | |
AR218296A1 (es) | Procedimiento para la preparacion de nuevos derivados de 14-beta-amino-morfina | |
AR217426A1 (es) | Procedimiento para la preparacion de nuevos derivados de 7-(3-indoliloxi,naftiloxi o fenoxi-2-hidroxi-propilamino-alquil)-teofilina | |
AR217688A1 (es) | Procedimiento para la preparacion de derivados de trans-2-sustituido-5-aril-2,3,4,4a,5,9b-hexahidro-1h-pirido(4,3-b)-indol | |
AR220730A1 (es) | Procedimiento para la preparacion de nuevos derivados de la i-((benzoxatiolil)-metil)-4-heterociclil-piperazina | |
AR223656A1 (es) | Procedimiento para obtener derivados de 2-feniliminoimidazolidina | |
AR222844A1 (es) | Procedimiento para la obtencion de nuevos derivados de n1-glucofuranosil-6-ilo-n3-nitroso-ureas | |
AR223465A1 (es) | Procedimiento para obtener derivados de 5-bencil-2,4-diamino-pirimidinas | |
MX4884E (es) | Procedimiento para la preparacion de derivados de la tienopiridina | |
ES480121A0 (es) | Un procedimiento para la preparacion de nuevos derivados de quinazolina. | |
AR225415A1 (es) | Procedimiento para la obtencion de nuevos derivados de pirido(2,1-b)quinazolina | |
AR218933A1 (es) | Procedimiento para obtener derivados de oxazolidona-2 | |
AR230835A1 (es) | Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido | |
ES494211A0 (es) | Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos. | |
MX5454E (es) | Procedimiento para preparar derivados de la 1,2,4-triazin-5-ona |